HomeCAI • NASDAQ
add
Caris Life Sciences Inc
Previous close
$29.49
Day range
$28.87 - $30.50
Year range
$25.42 - $33.41
Market cap
8.42B USD
Avg Volume
681.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 120.92M | 49.88% |
Operating expense | 115.01M | -2.81% |
Net income | -102.58M | 7.61% |
Net profit margin | -84.84 | 38.35% |
Earnings per share | — | — |
EBITDA | -50.91M | 31.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 33.43M | -72.51% |
Total assets | 291.58M | — |
Total liabilities | 645.34M | — |
Total equity | -353.75M | — |
Shares outstanding | 35.24M | — |
Price to book | -0.40 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -102.58M | 7.61% |
Cash from operations | -31.34M | 57.61% |
Cash from investing | -2.69M | -104.51% |
Cash from financing | 1.28M | -99.36% |
Net change in cash | -32.74M | -117.62% |
Free cash flow | — | — |
About
Founded
2008
Headquarters
Website
Employees
1,769
